Moderna mRNA Vaccine - Search News

FDA Approves 1st mRNA Flu Vaccine

Digest more

· 21h · on MSN

FDA approves first mRNA flu vaccine in win for Moderna after arduous review

The decision caps a seven-month process that included a rare refusal to consider the shot.

· 20h

Moderna’s mRNA flu vaccine gets FDA approval: Here's what's different

· 13h · on MSN

Moderna's mRNA flu vaccine gets approved after rare FDA refusal to review. What changed?

· 1d

US FDA approves first mRNA flu shot from Moderna

The U.S. Food and Drug Administration has approved Moderna's (MRNA.O) flu vaccine for people aged 50 and older, the company said on Wednesday, marking the first approval of a messenger RNA-based vacci...

· 1d

FDA approves first mRNA-based flu vaccine

· 14h

FDA approves first-ever mRNA flu vaccine for millions of older Americans

· 1d

Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA

“The FDA approval of mFLUSIVA, our fourth approved product in the United States and the first mRNA-based flu vaccine, demonstrates the continued strength and versatility of our mRNA platform,” said St...

· 14h

FDA approves first mRNA vaccine for seasonal flu

· 1d

FDA Approves First mRNA Flu Vaccine in Win for Moderna After Arduous Review

A new flu vaccine geared to older people is coming soon

The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season. Moderna, the vaccine's maker

GlobalData on MSN

Moderna adds new cohort to Phase III vaccine trial after interim data miss

The Phase III trial on mRNA-1403 will continue blinded as Moderna enrols the new cohort.

Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna’s Investigational Vaccine Against Bundibugyo Ebolavirus

Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no licensed vaccines

Tech Times on MSN

Moderna's mRNA Ebola vaccine enters human trials: Platform speed meets cold-chain wall in Ituri

Moderna mRNA Ebola vaccine mRNA-1469 entered Phase 1 trials in Canada on August 4, 2026 — making Canada the second country, after the UK, to test a Bundibugyo-specific shot. The mRNA platform's cold-chain requirement means it cannot reach Ituri Province,